Lantern Pharma (LTRN) Q1 2025 Annual Earnings
LTRN·Reported May 15, 2025·Before market open
Diluted EPS came in at $-0.42 (+17.6% YoY), beat the $-0.49 consensus by $0.07.
Diluted EPS
$-0.42beat by $0.07
Consensus: $-0.49
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Lantern Pharma's Q1 2025 earnings report.
Lantern Pharma (LTRN) reported Q1 2025 earnings on May 15, 2025 before market open.
Lantern Pharma reported diluted EPS of $-0.42 for Q1 2025.
EPS beat the consensus estimate of $-0.49 by $0.07.
Compared to the same quarter a year prior, diluted EPS grew 17.6% from $-0.51.
You can read the 10-K/A periodic report (0001641172-25-006728) directly on SEC EDGAR. The filing index links above go to sec.gov.